Ascletis Appoints Mr. Joshua Zhongbao Ling as VP Finance

Ascletis Pharma Inc. has announced that Mr. Joshua Zhongbao Ling joined Ascletis as Vice President of Finance. Mr. Ling ...

August 30, 2018 | Thursday | News
Ping An Good Doctor collaborates with Jointown

China's leading one-stop healthcare ecosystem platform, Ping An Good Doctor recently announced its strategic partnership...

August 30, 2018 | Thursday | News
DNAnexus brings Chance to Win Free de novo Assembly

 DNAnexus, the global leader in genome informatics and data management, today announced details of an opportun...

August 29, 2018 | Wednesday | News
BeiGene Announces Acceptance of its First NDA for Zanubrutinib

China's commercial-stage biopharmaceutical company BeiGene,   recently announced the acceptance by the Ch...

August 28, 2018 | Tuesday | News
Chongqing connectivity initiative’s first eldercare service collaboration

Singapore – ECON Healthcare Group signed a Memorandum of Understanding (MOU) with Chongqing Civil Affairs Bureau u...

August 28, 2018 | Tuesday | News
Strategia Holdings, JS InnoPharm team up for drug development

Strategia Holdings, LLC has announced a strategic partnership alliance with JS InnoPharm (Shanghai), Ltd. to facilitate ...

August 28, 2018 | Tuesday | News
Mabpharm seeks to raise capital through Hong Kong IPO

Mabpharm, a CDH Investments-backed Chinese biopharmaceutical firm has filed for an initial public offering in Hong ...

August 27, 2018 | Monday | News
China Biologic announces updates on unsolicited acquisition proposals

China Biologic Products Holdings, a leading fully integrated plasma-based biopharmaceutical company in China, announced ...

August 24, 2018 | Friday | News
GL Capital invests $12.5 M in Oxford BioDynamics

GL Capital, a healthcare-focused value-driven investment management group in China, has invested $12.5 million in UK-lis...

August 24, 2018 | Friday | News
Researchers decode the structure of a human Frizzled receptor

The Xu lab at Shanghai University's iHuman Institute has deciphered the high-resolution crystal structure of the fi...

August 23, 2018 | Thursday | News
GENETRON 3D gets launch approval to ease liquid biopsy of tumor

At the end of 2017, Chongqing Food and Drug Administration of China Food and Drug Administration (CFDA) officially appro...

August 22, 2018 | Wednesday | News
IsoPlexis expands in APAC, inks deal with Tekon Biotech

IsoPlexis Corporation (IsoPlexis), a privately held life sciences company at the forefront of single-cell analytics tech...

August 22, 2018 | Wednesday | News
Harbour BioMed announces partnership with Kelun-Biotech

Harbour BioMed has announced it has entered into an exclusive strategic partnership with Sichuan Kelun-Biotech Biopharma...

August 21, 2018 | Tuesday | News
Proposal to acquire China Biologic Products for $118.00 Per Share in Cash

A consortium composed of Mr. David (Xiaoying) Gao, GL Capital Group, Bank of China Group Investment Limited and CDH Inve...

August 21, 2018 | Tuesday | News
CFDA's Institute of Executive Development signs MoU with UL

The China Food and Drug Administration's Institute of Executive Development (CFDAIED) has signed an exclusive memorandum...

August 21, 2018 | Tuesday | News
Roche's Alecensa receives 'priority review' designation from CNDA

Roche  recently announced that the China National Drug Administration (CNDA) has granted marketing authorization fo...

August 21, 2018 | Tuesday | News
Adlai Nortye opens Boston Innovation Centre

Adlai Nortye, a Hangzhou biopharma, has announced the opening of its first US site in Boston, Massachusetts. The Boston ...

August 20, 2018 | Monday | News
HitGen collaborates with LG Chem

HitGen Ltd has announced a multi-year major drug discovery research collaboration with LG Chem to identify novel small m...

August 20, 2018 | Monday | News